Filing Details
- Accession Number:
- 0001209191-20-028481
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-12 16:12:25
- Reporting Period:
- 2020-05-11
- Accepted Time:
- 2020-05-12 16:12:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Therapeutics Public Ltd Co | HZNP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230482 | W Jeffrey Sherman | C/O Horizon Pharma Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp And Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-05-11 | 33,479 | $4.96 | 47,445 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-05-11 | 33,479 | $45.00 | 13,966 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock option (right to buy) | Disposition | 2020-05-11 | 33,479 | $0.00 | 33,479 | $4.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-12-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 287,897 | Indirect | By Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2020.
- The stock option is fully vested and exercisable.